Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze ORGO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ORGO investment potential.

What is ORGO stock price today?

Get real-time ORGO stock price, historical data, and price charts on Financhill. Track ORGO performance with our advanced analysis tools.

Is ORGO a good investment?

Evaluate ORGO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ORGO stock?

To buy ORGO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ORGO?

View detailed market capitalization data and company valuation metrics for ORGO on our comprehensive analysis page.

What is the P/E ratio of ORGO?

Use our fundamental analysis tools to view ORGO P/E ratio and compare valuation metrics with industry peers.

What are ORGO earnings?

View ORGO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Organogenesis Holdings, Inc. 10K Form

Buy

ORGO
Organogenesis Holdings, Inc.

Last Price:

$5.61

Seasonality Move:

37.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10	10Q	ORGO/Organogenesis Holdings, Inc. Quarterly
2020-05-11	10Q	ORGO/Organogenesis Holdings, Inc. Quarterly
2020-04-29	10K	ORGO/Organogenesis Holdings, Inc. Annual
2020-03-09	10K	ORGO/Organogenesis Holdings, Inc. Annual
2019-11-12	10Q	ORGO/Organogenesis Holdings, Inc. Quarterly
2019-08-09	10Q	ORGO/Organogenesis Holdings, Inc. Quarterly

Receive ORGO News And Ratings

See the #1 stock for the next 7 days that we like better than ORGO

ORGO Financial Statistics

Sales & Book Value

Annual Sales:	$482M
Cash Flow:	$844K
Price / Cash Flow:	96.73
Annual Sales:	$2.01
Price / Book:	2.79

Profitability

EPS (TTM):	-0.09810
Net Income (TTM):	$1M
Gross Margin:	$349.1M
Return on Equity:	0.28%
Return on Assets:	0.21%

Organogenesis Holdings, Inc. Earnings Forecast

Key Organogenesis Holdings, Inc. Financial Ratios

The Gross Profit Margin over the past 9 years for ORGO is 72.43%.
The Selling, General & Administrative Expenses for ORGO have been equal to 61.10% of Gross Profit Margin.
The Research & Development expenses have been 10.43% of Revenue.
The Interest Expense is 179.33% of Operating Income.
The Net Earning history of ORGO is 0.18% of Total Revenues.
Per Share Earnings over the last 9 years have been positive in 4 years.

Organogenesis Holdings, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	ORGO
CUSIP:	68621F
Website:	organogenesis.com

Debt

Debt-to-Equity Ratio:	0.11
Current Ratio:	3.32
Quick Ratio:	2.73

Price-to-Earnings

Trailing P/E Ratio:	861.54
Forward P/E Ratio:	32.94

ORGO Technical Analysis vs Fundamental Analysis

Buy

Organogenesis Holdings, Inc. (ORGO) is a Buy

Is Organogenesis Holdings, Inc. a Buy or a Sell?

Organogenesis Holdings, Inc. stock is rated a Buy

The current Organogenesis Holdings, Inc. [ORGO] share price is $5.60. The Score for ORGO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.